Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Remodulin (treprostinil sodium) Injection, 1.0, 2.5, 5.0, and 10.0 mg/ml United Therapeutics NDA 21-272 | Remodulin (treprostinil sodium) injection, United Therapeutics, Labeling Revision | Remodulin (treprostinil sodium) Injection, United Therapeutics, Accelerated Approval | Remodulin (treprostinil sodium) Injection, United Therapeutics, Labeling Revision | Remodulin (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision | Remodulin (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision | Remodulin (treprostinil sodium) I.V. Injection, United Therapeutics Corp., Labeling Revision | Remodulin (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision | Tyvaso (treprostinil sodium) Inhalation Solution, United Therapeutics Corp., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com